Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction

Fuyuko Takata; Shinsuke Nakagawa; Junichi Matsumoto; Shinya Dohgu

doi:10.3389/fncel.2021.661838

journal article Open Access Sep 13, 2021

Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction

Fuyuko Takata Shinsuke Nakagawa

Junichi Matsumoto Shinya Dohgu

Frontiers in Cellular Neuroscience Vol. 15 · Frontiers Media SA

View at Publisher Save 10.3389/fncel.2021.661838

Abstract

Neuroinflammation is involved in the onset or progression of various neurodegenerative diseases. Initiation of neuroinflammation is triggered by endogenous substances (damage-associated molecular patterns) and/or exogenous pathogens. Activation of glial cells (microglia and astrocytes) is widely recognized as a hallmark of neuroinflammation and triggers the release of proinflammatory cytokines, leading to neurotoxicity and neuronal dysfunction. Another feature associated with neuroinflammatory diseases is impairment of the blood-brain barrier (BBB). The BBB, which is composed of brain endothelial cells connected by tight junctions, maintains brain homeostasis and protects neurons. Impairment of this barrier allows trafficking of immune cells or plasma proteins into the brain parenchyma and subsequent inflammatory processes in the brain. Besides neurons, activated glial cells also affect BBB integrity. Therefore, BBB dysfunction can amplify neuroinflammation and act as a key process in the development of neuroinflammation. BBB integrity is determined by the integration of multiple signaling pathways within brain endothelial cells through intercellular communication between brain endothelial cells and brain perivascular cells (pericytes, astrocytes, microglia, and oligodendrocytes). For prevention of BBB disruption, both cellular components, such as signaling molecules in brain endothelial cells, and non-cellular components, such as inflammatory mediators released by perivascular cells, should be considered. Thus, understanding of intracellular signaling pathways that disrupt the BBB can provide novel treatments for neurological diseases associated with neuroinflammation. In this review, we discuss current knowledge regarding the underlying mechanisms involved in BBB impairment by inflammatory mediators released by perivascular cells.

Topics

No keywords indexed for this article. Browse by subject →

References

234

[1]

Ahmad "PGD2 DP1 receptor stimulation following stroke ameliorates cerebral blood flow and outcomes." Neuroscience (2014) 10.1016/j.neuroscience.2014.08.050

[2]

Al-Bachari "Blood-brain barrier leakage is increased in Parkinson’s disease." Front. Physiol. (2020) 10.3389/fphys.2020.593026

[3]

Alkabie "SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties." J. Neuroinflammation (2016) 10.1186/s12974-016-0657-9

[4]

Alvarez "Disruption of central nervous system barriers in multiple sclerosis." Biochim. Biophys. Acta (2011) 10.1016/j.bbadis.2010.06.017

[5]

Alves "Sphingosine-1-phosphate protects against brain microvascular endothelial junctional protein disorganization and barrier dysfunction caused by alcohol." Microcirculation (2019) 10.1111/micc.12506

[6]

András "The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells." J. Cereb. Blood Flow Metab. (2007) 10.1038/sj.jcbfm.9600445

[7]

András "Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells." J. Cereb. Blood Flow Metab. (2005) 10.1038/sj.jcbfm.9600115

[8]

Aslam "TNF-alpha induced NFkappaB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells." Cytokine (2012) 10.1016/j.cyto.2011.10.016

[9]

Bai "Silencing microRNA-143 protects the integrity of the blood-brain barrier: implications for methamphetamine abuse." Sci. Rep. (2016) 10.1038/srep35642

[10]

Bauer "Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement." J. Cereb. Blood Flow Metab. (2010) 10.1038/jcbfm.2009.248

[11]

Bauer "The neuropoietic cytokine family in development, plasticity, disease and injury." Nat. Rev. Neurosci. (2007) 10.1038/nrn2054

[12]

Beard "Non-muscle Mlck is required for beta-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1beta-mediated barrier dysfunction in brain endothelial cells." J. Cell Sci. (2014) 10.1242/jcs.144550

[13]

Beers "Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies." Lancet Neurol. (2019) 10.1016/s1474-4422(18)30394-6

[14]

Bell "Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging." Neuron (2010) 10.1016/j.neuron.2010.09.043

[15]

Black "Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats." Ann. Neurol. (1985) 10.1002/ana.410180313

[16]

Blamire "Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study." J. Neurosci. (2000) 10.1523/jneurosci.20-21-08153.2000

[17]

Blood‐brain barrier breakdown, neuroinflammation, and cognitive decline in older adults

Gene L. Bowman, Loïc Dayon, Richard Kirkland et al.

Alzheimer's & Dementia 2018 10.1016/j.jalz.2018.06.2857

[18]

Bowman "Blood-brain barrier impairment in Alzheimer disease: stability and functional significance." Neurology (2007) 10.1212/01.wnl.0000262031.18018.1a

[19]

Bukeirat "MiR-34a regulates blood-brain barrier permeability and mitochondrial function by targeting cytochrome c." J. Cereb. Blood Flow Metab. (2016) 10.1177/0271678x15606147

[20]

Burek "Hypoxia-induced MicroRNA-212/132 alter blood-brain barrier integrity through inhibition of tight junction-associated proteins in human and mouse brain microvascular endothelial cells." Transl. Stroke Res. (2019) 10.1007/s12975-018-0683-2

[21]

Camire "Transitory loss of glia and the subsequent modulation in inflammatory cytokines/chemokines regulate paracellular claudin-5 expression in endothelial cells." J. Neuroimmunol. (2015) 10.1016/j.jneuroim.2015.05.008

[22]

Camm "Cardiac and vascular effects of fingolimod: mechanistic basis and clinical implications." Am. Heart J. (2014) 10.1016/j.ahj.2014.06.028

[23]

Cao "S1PR2 antagonist alleviates oxidative stress-enhanced brain endothelial permeability by attenuating p38 and Erk1/2-dependent cPLA2 phosphorylation." Cell Signal (2019) 10.1016/j.cellsig.2018.09.019

[24]

Caruso "Ultrastructural descriptions of pericyte/endothelium peg-socket interdigitations in the microvasculature of human gastric carcinomas." Anticancer Res. (2009)

[25]

Chan "Aβ(1-42) oligomer induces alteration of tight junction scaffold proteins via RAGE-mediated autophagy in bEnd.3 cells." Exp. Cell Res. (2018) 10.1016/j.yexcr.2018.05.025

[26]

Chen "5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer’s disease." Brain Behav. Immun. (2020) 10.1016/j.bbi.2020.03.022

[27]

Chen "Hypertonic saline protects brain endothelial cells against hypoxia correlated to the levels of epidermal growth factor receptor and interleukin-1beta." Medicine (Baltimore) (2017) 10.1097/md.0000000000005786

[28]

Chen "The AMPAR antagonist perampanel protects the neurovascular unit against traumatic injury via regulating Sirt3." CNS Neurosci. Ther. (2021) 10.1111/cns.13580

[29]

Chitnis "CNS inflammation and neurodegeneration." J. Clin. Invest. (2017) 10.1172/jci90609

[30]

Coelho-Santos "The TNF-alpha/NF-kappaB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunction." J. Cereb. Blood Flow Metab. (2015) 10.1038/jcbfm.2015.59

[31]

Correale "Progressive multiple sclerosis: from pathogenic mechanisms to treatment." Brain (2017)

[32]

Corrigan "Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation." J. Neuroinflammation (2016) 10.1186/s12974-016-0738-9

[33]

Cruz-Orengo "Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility." J. Clin. Invest. (2014) 10.1172/jci73408

[34]

Cuevas "Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro." Metab. Brain Dis. (2019) 10.1007/s11011-019-00447-8

[35]

da Fonseca "The impact of microglial activation on blood-brain barrier in brain diseases." Front. Cell Neurosci. (2014) 10.3389/fncel.2014.00362

[36]

Dalvi "Exogenous arachidonic acid mediates permeability of human brain microvessel endothelial cells through prostaglandin E2 activation of EP3 and EP4 receptors." J. Neurochem. (2015) 10.1111/jnc.13117

[37]

Daneman "The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells." PLoS One (2010) 10.1371/journal.pone.0013741

[38]

de Vries "The influence of cytokines on the integrity of the blood-brain barrier in vitro." J. Neuroimmunol. (1996) 10.1016/0165-5728(95)00148-4

[39]

Defazio "Inhibition of protein kinase C counteracts TNFalpha-induced intercellular adhesion molecule 1 expression and fluid phase endocytosis on brain microvascular endothelial cells." Brain Res (2000) 10.1016/s0006-8993(00)02127-2

[40]

Deli "Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology." Cell. Mol. Neurobiol. (2005) 10.1007/s10571-004-1377-8

[41]

Deli "Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin." J. Neurosci. Res. 10.1002/jnr.490410602

[42]

Deli "Penetration of small molecular weight substances through cultured bovine brain capillary endothelial cell monolayers: the early effects of cyclic adenosine 3′,5′-monophosphate." Exp. Physiol. 10.1113/expphysiol.1995.sp003877

[43]

DeMars "Protective effects of L-902,688, a prostanoid EP4 receptor agonist, against acute blood-brain barrier damage in experimental ischemic stroke." Front. Neurosci. (2018) 10.3389/fnins.2018.00089

[44]

Dohgu "Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF." J. Neuroinflammation (2011) 10.1186/1742-2094-8-167

[45]

Dohgu "Monomeric α-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro." Microvasc. Res. (2019) 10.1016/j.mvr.2019.03.005

[46]

Du "Omarigliptin mitigates lipopolysaccharide-induced neuroinflammation and dysfunction of the integrity of the blood-brain barrier." ACS Chem. Neurosci. (2020) 10.1021/acschemneuro.0c00537

[47]

Dusaban "Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes." J. Neuroinflammation (2017) 10.1186/s12974-017-0882-x

[48]

Ensoli "Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma." Mult. Scler. (2002) 10.1191/1352458502ms817oa

[49]

Fang "MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats." FASEB J. (2016) 10.1096/fj.201500126

[50]

Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

Lisa Fellner, Regina Irschick, Kathrin Schanda et al.

Glia 2013 10.1002/glia.22437

Showing 50 of 234 references

Cited By

535

Unraveling the complexities: A comprehensive review of severe fever with thrombocytopenia syndrome and its associated complications

Yumo Zhou, Yanfu Wang · 2026

iScience

Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation

Ludmila Müller, Svetlana Di Benedetto · 2025

Frontiers in Cellular Neuroscience

Role of dietary fiber and short-chain fatty acids in preventing neurodegenerative diseases through the gut-brain axis

Uyory Choe · 2025

Journal of Functional Foods

From spreading depolarization to blood–brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy

Gerben Van Hameren, Refat Aboghazleh · 2024

Nature Reviews Neurology

HDAC1 is Involved in Neuroinflammation and Blood-Brain Barrier Damage in Stroke Pathogenesis

Hao-Kuang Wang, Yu-Ting Su · 2023

Journal of Inflammation Research

Metrics

535

Citations

234

References

Details

Published: Sep 13, 2021
Vol/Issue: 15
License: View

Authors

Cite This Article

Fuyuko Takata, Shinsuke Nakagawa, Junichi Matsumoto, et al. (2021). Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction. Frontiers in Cellular Neuroscience, 15. https://doi.org/10.3389/fncel.2021.661838

Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction

You May Also Like